New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who ...

The cumulative data from the Phase 1 study indicate that salanersen has a generally well tolerated safety profile at both the 40 mg and 80 mg doses, with most adverse events (AEs) mild to moderate in ...

New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who transitioned to the investigational higher dose regimen of nusinersen from 12 mg SP ...

Scientists have discovered what really separates a cold-blooded psychopath from the average person. A team from the ...

Tariff Update, Music Rights, Gold Price, Animal Communication & Dino School ...

SUNRISE-PD is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled trial with a hybrid decentralized design that will last 20 weeks from the initial screening phase to the safety ...

Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness ...

The human brain is comprised of two main types of cells, known as neurons and glia. The first are responsible for ...

Motor neuron disease (MND) is a devastating condition that causes progressive muscle weakness by damaging the motor neurons, the nerve cells that connect the brain to muscles.

The occupation at higher risk of developing motor neurone disease Unlike many chronic conditions linked to lifestyle, where being ‘unhealthy’ increases risk, MND doesn’t follow the usual rules ...